Have a personal or library account? Click to login
Incidental Finding of Parathyroid Adenoma in a Patient with Breast Carcinoma Detected by PET/CT 18F -FDG Examination and Confirmed by 99 mTc -Terofosmin SPECT/CT Cover

Incidental Finding of Parathyroid Adenoma in a Patient with Breast Carcinoma Detected by PET/CT 18F -FDG Examination and Confirmed by 99 mTc -Terofosmin SPECT/CT

Open Access
|Jun 2024

References

  1. Neumann DR, Esselstyn CB, Maclntyre WJ, Go RT, Obuchowski NA, Chen EQ, et al. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med. 1996;37(11):1809-15. PMid:8917180
  2. Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med. 1995;22(6):556-8. https://doi.org/10.1007/BF00817282
  3. Vallejos V, Martin-Comin J, Gonzalez MT, Rafecas R, Munoz A, Fernandez A, et al. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands. Clin Nucl Med. 1999;24(12):959-64. https://doi.org/10.1097/00003072-199912000-00011 PMid:10595477
  4. Gallowitsch HJ, Mikosch P, Kresnik E, Gomez I, Lind P. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism. Invest Radiol. 1997;32(8):459-65. https://doi.org/10.1097/00004424-199708000-00005 PMid:9258734
  5. Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Lind P. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area. Invest Radiol. 2000;35(8):453-96. https://doi.org/10.1097/00004424-200008000-00001 PMid:10946972
  6. Prior JO. New scintigraphic methods for parathyroid imaging. Ann Endocrinol (Paris). 2015;76(2):145-7. https://doi.org/10.1016/j.ando.2015.03.026 PMid:25913525
  7. Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Gosnell JE, Shen WT, et al. Use of PET tracers for parathyroid localization: A systematic review and meta-analysis. Langenbecks Arch Surg. 2016;401(7):925-35. https://doi.org/10.1007/s00423-016-1425-0 PMid:27086309
  8. Vallabhajosula S. 18f-labeled positron emission tomographic radiopharmaceuticals in oncology: An overview of radiochemistry and mechanisms of tumor localization. Semin Nucl Med. 2007;37(6):400-19. https://doi.org/10.1053/j.semnuclmed.2007.08.004 PMid:17920348
  9. Ishizuka T, Kajita K, Kamikubo K, Komaki T, Miura K, Nagao S, et al. Phospholipid/Ca2+-dependent protein kinase activity in human parathyroid adenoma. Endocrinol Jpn. 1987;34(6):965-8. https://doi.org/10.1507/endocrj1954.34.965 PMid:3450512
  10. Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: A systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46(3):751-65. https://doi.org/10.1007/s00259-018-4123-z PMid:30094461
Language: English
Page range: 335 - 338
Submitted on: Apr 20, 2024
Accepted on: May 20, 2024
Published on: Jun 18, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Albena Botushanova, Aleksandar Botushanov, Nikolay Botushanov, Veselin Popov, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.